Data shows no increase in pediatric hepatitis, adenovirus 40/41 compared to pre-pandemic levelsJune 21st 2022
Data from Morbidity and Mortality Weekly Report showed that there was no demonstrated increase in pediatric hepatitis or adenovirus 40/41 above pre-COVID-19 pandemic baseline levels.
FDA committee recommends Pfizer-BioNTech, Moderna COVID-19 vaccines for kids 6 months and olderJune 15th 2022
The US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee unanimously voted recently to recommend both the Pfizer-BioNTech and Moderna COVID-19 vaccines for individuals aged 6 months and older.
Donna Hallas discusses the Pfizer-BioNTech vaccine booster for children 5 to 11 years oldMay 19th 2022
Contemporary Pediatrics® Editorial Advisory Board member Donna Hallas shares her thoughts on the recent authorization of a Pfizer-BioNTech COVID-19 booster shot for children 5-11 years old.